Share

January 29, 2013; 80 (5) Editorial

Making sense of genetic heterogeneity

Emergence of pathways in developmental brain disorders

Alex R. Paciorkowski, Basil T. Darras
First published January 2, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31827f101c
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
164

Share

Article Information

vol. 80 no. 5 426-427
DOI: 
https://doi.org/10.1212/WNL.0b013e31827f101c
PubMed: 
23284070
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published January 2, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Alex R. Paciorkowski, MD and
    2. Basil T. Darras, MD
  1. Alex R. Paciorkowski, MD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Basil T. Darras, MD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) Athena Diagnostics, Honorarium for Virtual Grand, Rounds (SMA) - 2010

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Various titles, UpToDate, 1999-present

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) ISIS Pharmaceuticals, (2) Quest Diagnostics, (3) Guidepoint Global Consultation, (4) Easton Associates Consultation, (5) Gershon Lehrman Group

    Speakers' Bureaus:

    1. (1) Athena Diagnostics

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) PTC Therapeutics, (2) Isis Pharmaceuticals

    Research Support, Government Entities:

    1. (1) NIH/NIAMS, 2P01 NS040828-6A11, co-PI, 2000-2012. (2) NIH/NINDS, 1U10NS077269, co-PI/PD, 2011-2018. (3) NIH/NIAMS, 1R01AR060850, co-PI, 2011-2015.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) SMA Foundation, (2) Muscular Dystrophy Association, (3) Slaney Family Fund for SMA

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology, Pediatrics, and Biomedical Genetics (A.R.P.), Center for Neural Development & Disease, University of Rochester Medical Center, Rochester, NY; and Department of Neurology (B.T.D.), Boston Children's Hospital, Harvard Medical School, Boston, MA.
  1. Correspondence to Dr. Paciorkowski: alex_paciorkowski{at}urmc.rochester.edu
View Full Text

Article usage

Article usage: January 2013 to January 2020

AbstractFullPdfSource
Jan 201301571Highwire
Feb 201301520Highwire
Mar 2013086Highwire
Apr 2013058Highwire
May 2013022Highwire
Jun 20131532Highwire
Jul 20131144Highwire
Aug 2013810Highwire
Sep 20131703Highwire
Oct 20131301Highwire
Nov 2013343Highwire
Dec 2013825Highwire
Jan 2014311Highwire
Feb 2014622Highwire
Mar 2014721Highwire
Apr 20141154Highwire
May 2014300Highwire
Jun 20141422Highwire
Jul 20141321Highwire
Aug 2014721Highwire
Sep 2014510Highwire
Oct 20141510Highwire
Nov 2014200Highwire
Dec 2014700Highwire
Jan 2015641Highwire
Feb 2015811Highwire
Mar 20151211Highwire
Apr 2015700Highwire
May 2015711Highwire
Jun 20151612Highwire
Jul 20151600Highwire
Aug 20151331Highwire
Sep 20151200Highwire
Oct 2015911Highwire
Nov 2015600Highwire
Dec 20151410Highwire
Jan 2016900Highwire
Feb 2016811Highwire
Mar 2016400Highwire
Apr 2016400Highwire
May 2016222Highwire
Jun 2016800Highwire
Jul 20163000Highwire
Aug 20161700Highwire
Sep 2016800Highwire
Oct 20161702Highwire
Nov 20161000Highwire
Dec 2016900Highwire
Jan 20171810Highwire
Feb 2017511Highwire
Mar 2017500Highwire
Apr 2017600Highwire
May 20171000Highwire
Jun 2017900Highwire
Jul 2017100Highwire
Aug 2017711Highwire
Sep 2017601Highwire
Oct 2017611Highwire
Nov 2017300Highwire
Dec 20171700Highwire
Jan 2018900Highwire
Feb 20181700Highwire
Mar 20182601Highwire
Apr 20182111Highwire
May 20182000Highwire
Jun 2018800Highwire
Jul 20181310Highwire
Aug 2018301Highwire
Sep 20181201Highwire
Oct 2018501Highwire
Nov 2018810Highwire
Dec 2018500Highwire
Jan 2019502Highwire
Feb 2019400Highwire
Mar 2019700Highwire
Apr 2019200Highwire
May 2019820Highwire
Jun 2019700Highwire
Jul 2019531Highwire
Aug 2019101Highwire
Sep 2019100Highwire
Oct 20191100Highwire
Nov 2019800Highwire
Dec 2019401Highwire
Jan 2020400Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me